A cancer-associated mutant of METTL14, R298P, targets the heterodimer to both canonical 5ʹ-AC-3ʹ methylation sites and aberrant 5ʹ-AU-3ʹ methylation sites, altering the m6A methylation profile and target gene expression [69]. This evidence concerns the gene METTL14 and cancer.